Radiosynthesis and evaluation of novel [ 99m Tc(I)] + and [ 99m Tc(I)(CO) 3 ] + complexes with a 4‐nitroimidazole isocyanide for imaging tumor hypoxia-Reference-Cited by-同舟云学术

Radiosynthesis and evaluation of novel [ 99m Tc(I)] + and [ 99m Tc(I)(CO) 3 ] + complexes with a 4‐nitroimidazole isocyanide for imaging tumor hypoxia

Published:2020-05-15 Issue:9 Volume:34 Page:
ISSN:0268-2605
Container-title:Applied Organometallic Chemistry
language:en
Short-container-title:Appl Organomet Chem

Author:

Ruan Qing¹,Zhang Xuran¹,Zhang Junbo¹^ORCID

Affiliation:

1. Key Laboratory of Radiopharmaceuticals of Ministry of Education, College of ChemistryBeijing Normal University Beijing 100875 China

Funder

Beijing Municipal Science and Technology Commission

National Natural Science Foundation of China

Publisher

Wiley

Subject

Inorganic Chemistry,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/aoc.5798

Reference24 articles.

1. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment

2. Radiopharmaceuticals in Tumor Hypoxia Imaging: A Review Focused on Medicinal Chemistry Aspects

3. Targeting hypoxia in cancer therapy

4. Bifunctional Metal – Nitroimidazole Complexes for Hypoxia Theranosis in Cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and Evaluation of a Novel ^99mTc-Labeled Niraparib Isonitrile Complex as a Potential PARP-1 Imaging Agent;Molecular Pharmaceutics;2024-06-06

2. Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors;Pharmaceutics;2023-06-27

3. Preclinical assessment of Alzheimer's disease using novel designed ^99m Tc‐labeled RGD‐based pro‐apoptotic cyclic peptide as a promising SPECT agent;Applied Organometallic Chemistry;2022-01-02

4. Hypoxia targeting lutetium-177-labeled nitroimidazole-decorated gold particles as cancer theranostic nanoplatforms;Materials Advances;2022

5. Synthesis and Biological Evaluation of 99mTc-Labeled Phenylpiperazine Derivatives as Selective Serotonin-7 Receptor Ligands for Brain Tumor Imaging;Molecular Pharmaceutics;2021-05-24